Trinity Biotech ROA 2010-2024 | TRIB
Current and historical return on assets (ROA) values for Trinity Biotech (TRIB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Trinity Biotech ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-12-31 | $-0.03B | $0.10B | -33.33% |
| 2024-09-30 | $-0.02B | $0.10B | -24.71% |
| 2024-06-30 | $-0.02B | $0.09B | -29.97% |
| 2024-03-31 | $-0.02B | $0.09B | -30.88% |
| 2023-12-31 | $-0.03B | $0.06B | -34.97% |
| 2023-09-30 | $-0.03B | $0.06B | -36.36% |
| 2023-06-30 | $-0.03B | $0.07B | -35.13% |
| 2023-03-31 | $-0.04B | $0.09B | -36.08% |
| 2022-12-31 | $-0.04B | $0.09B | -40.69% |
| 2022-09-30 | $-0.03B | $0.10B | -29.77% |
| 2022-06-30 | $-0.02B | $0.11B | -19.34% |
| 2022-03-31 | $-0.01B | $0.11B | -10.99% |
| 2021-12-31 | $0.00B | $0.12B | 0.80% |
| 2021-09-30 | $-0.01B | $0.12B | -6.23% |
| 2021-06-30 | $0.00B | $0.13B | -1.52% |
| 2021-03-31 | $0.00B | $0.14B | -1.51% |
| 2020-12-31 | $-0.01B | $0.13B | -4.58% |
| 2020-09-30 | $-0.02B | $0.14B | -14.48% |
| 2020-06-30 | $-0.03B | $0.13B | -18.51% |
| 2020-03-31 | $-0.03B | $0.13B | -19.83% |
| 2019-12-31 | $-0.03B | $0.13B | -17.26% |
| 2019-09-30 | $-0.03B | $0.17B | -17.31% |
| 2019-06-30 | $-0.03B | $0.17B | -16.47% |
| 2019-03-31 | $-0.02B | $0.17B | -12.54% |
| 2018-12-31 | $-0.02B | $0.15B | -12.15% |
| 2018-09-30 | $-0.04B | $0.18B | -21.44% |
| 2018-06-30 | $-0.04B | $0.19B | -20.31% |
| 2018-03-31 | $-0.04B | $0.20B | -19.13% |
| 2017-12-31 | $-0.04B | $0.19B | -17.67% |
| 2017-09-30 | $-0.10B | $0.25B | -40.20% |
| 2017-06-30 | $-0.10B | $0.25B | -36.36% |
| 2017-03-31 | $-0.10B | $0.25B | -32.65% |
| 2016-12-31 | $-0.10B | $0.25B | -30.42% |
| 2016-09-30 | $0.00B | $0.36B | 0.83% |
| 2016-06-30 | $0.02B | $0.36B | 4.45% |
| 2016-03-31 | $0.02B | $0.36B | 4.73% |
| 2015-12-31 | $0.02B | $0.36B | 6.64% |
| 2015-09-30 | $0.02B | $0.36B | 7.63% |
| 2015-06-30 | $0.02B | $0.36B | 5.52% |
| 2015-03-31 | $0.02B | $0.25B | 6.63% |
| 2014-12-31 | $0.02B | $0.24B | 6.76% |
| 2014-09-30 | $0.02B | $0.24B | 7.31% |
| 2014-06-30 | $0.01B | $0.24B | 4.37% |
| 2014-03-31 | $0.01B | $0.23B | 4.54% |
| 2013-12-31 | $0.01B | $0.23B | 4.68% |
| 2013-09-30 | $0.01B | $0.22B | 4.36% |
| 2013-06-30 | $0.02B | $0.20B | 8.07% |
| 2013-03-31 | $0.02B | $0.20B | 8.27% |
| 2012-12-31 | $0.02B | $0.20B | 8.50% |
| 2012-09-30 | $0.02B | $0.19B | 8.80% |
| 2012-06-30 | $0.02B | $0.18B | 9.05% |
| 2012-03-31 | $0.02B | $0.18B | 9.26% |
| 2011-12-31 | $0.02B | $0.17B | 9.48% |
| 2011-09-30 | $0.02B | $0.17B | 9.62% |
| 2011-06-30 | $0.02B | $0.17B | 9.19% |
| 2011-03-31 | $0.06B | $0.17B | 38.87% |
| 2010-12-31 | $0.06B | $0.16B | 40.40% |
| 2010-09-30 | $0.06B | $0.16B | 41.74% |
| 2010-06-30 | $0.06B | $0.15B | 43.88% |
| 2010-03-31 | $0.01B | $0.13B | 9.14% |
| 2009-12-31 | $0.01B | $0.13B | 9.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.013B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.365B | 28.30 |
| Boston Scientific (BSX) | United States | $147.057B | 36.81 |
| Stryker (SYK) | United States | $145.454B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $130.907B | 0.00 |
| Medtronic (MDT) | Ireland | $112.941B | 16.01 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.659B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.106B | 27.97 |
| ResMed (RMD) | United States | $36.856B | 27.68 |
| Agilent Technologies (A) | United States | $34.008B | 22.17 |
| GE HealthCare Technologies (GEHC) | United States | $33.609B | 15.96 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.270B | 83.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.645B | 11.98 |
| Baxter (BAX) | United States | $16.114B | 12.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.196B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.264B | 21.80 |
| Lantheus Holdings (LNTH) | United States | $5.587B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.206B | 18.79 |
| Perrigo (PRGO) | Ireland | $3.763B | 9.54 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.435B | 15.65 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Envista Holdings (NVST) | United States | $3.259B | 27.08 |
| GN Store Nord (GNNDY) | Denmark | $2.362B | 19.57 |
| QuidelOrtho (QDEL) | United States | $2.094B | 14.40 |
| LeMaitre Vascular (LMAT) | United States | $1.878B | 41.99 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| Neogen (NEOG) | United States | $1.238B | 15.85 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| BioLife Solutions (BLFS) | United States | $1.128B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.075B | 24.19 |
| Kestra Medical Technologies (KMTS) | United States | $1.001B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.989B | 12.64 |
| InMode (INMD) | Israel | $0.903B | 9.10 |
| Evolus (EOLS) | United States | $0.660B | 0.00 |
| CeriBell (CBLL) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.606B | 5.03 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.340B | 60.40 |
| Canopy Growth (CGC) | Canada | $0.289B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| ZimVie (ZIMV) | United States | $0.265B | 12.06 |
| Cresco Labs (CRLBF) | United States | $0.261B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| OraSure Technologies (OSUR) | United States | $0.218B | 0.00 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.09 |
| Verano Holdings (VRNOF) | United States | $0.183B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 16.05 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.61 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.21 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |